Skip to main content

Main menu

  • Home
  • Content
    • Latest
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Alerts
    • Feedback
    • Folders
    • Help
  • Other Publications
    • Saudi Medical Journal

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Neurosciences Journal
  • Other Publications
    • Saudi Medical Journal
  • My alerts
  • Log in
Neurosciences Journal

Advanced Search

  • Home
  • Content
    • Latest
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Alerts
    • Feedback
    • Folders
    • Help
  • Follow psmmc on Twitter
  • Visit psmmc on Facebook
  • RSS
NewsCochrane library newsalert
Open Access

Clinical trial in pregnant women addresses detection of heart disorder in the fetus

Neurosciences Journal January 2024, 29 (1) 67;
  • Article
  • eLetters
  • Info & Metrics
  • References
  • PDF
Loading

NOVEMBER 10, 2023 - In the trial, called Surveillance To Prevent AV Block Likely to Occur Quickly (STOP BLOQ), the incidence of AVB increased with higher levels of anti-Ro/SSA antibodies, reaching 7.7% for those in the top quartile, which increased to 27.3% in those with a previous child who had AVB, although participant numbers in that category were small. Antibody titers did not change over time. The trial also revealed that home-based fetal heart rate monitoring reliably detected conduction abnormalities, which may reduce the need for serial echocardiograms.

“Examining the levels of anti-Ro/SSA antibodies is an important advance since for women with low titers, monitoring is probably not necessary and for those with high titers the increased risk supports surveillance,” said corresponding author Jill Buyon, MD, of NYU Langone Health. She added that this study also indicated that titers of antibodies do not change and that additional factors besides antibodies contribute to risk.

“That home monitoring can rapidly and accurately identify early fetal conduction disease is a major step forward that may significantly decrease the need for echocardiograms and hopefully facilitate reversibility,” added senior author and research professor Bettina Cuneo MD, of the University of Arizona-Tucson College of Medicine.

URL upon publication: https://onlinelibrary.wiley.com/doi/10.1002/art.42733

Full citation: “Prospective Evaluation of High Titer Autoantibodies and Fetal Home Monitoring in the Detection of Atrioventricular Block Among Anti-SSA/Ro Pregnancies.” Jill. P. Buyon, Mala Masson, Caroline G. Izmirly, Colin Phoon, Ruben Acherman, Elena Sinkovskaya, Alfred Abuhamad, Majd Makhoul, Gary Satou, Whitnee Hogan, Nelangi Pinto, Anita Moon-Grady, Lisa Howley, Mary Donofrio, Anita Krishnan, Homa Ahmadzia, Stephanie Levasseur, Erin Paul, Sonal Owens, Kristopher Cumbermack, Jyothi Matta, Gary Joffe, Christopher Lindblade, Caitlin Haxel, Katherine Kohari, Joshua Copel, James Strainic, Tam Doan, Karla Bermudez-Wagner, Conisha Holloman, Shreya S Sheth, Stacy Killen, Theresa Tacy, Michelle Kaplinski, Lisa Hornberger, Philip M. Carlucci, Peter Izmirly, Nicola Fraser, Robert M. Clancy, Bettina F. Cuneo. Arthritis Rheumatol; Published Online: 10 November 2023 (DOI: 10.1002/art.42733).

Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd., reproduced with permission.

  • Copyright: © Neurosciences

Neurosciences is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work.

PreviousNext
Back to top

In this issue

Neurosciences Journal: 29 (1)
Neurosciences Journal
Vol. 29, Issue 1
1 Jan 2024
  • Table of Contents
  • Cover (PDF)
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Neurosciences Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Clinical trial in pregnant women addresses detection of heart disorder in the fetus
(Your Name) has sent you a message from Neurosciences Journal
(Your Name) thought you would like to see the Neurosciences Journal web site.
Citation Tools
Clinical trial in pregnant women addresses detection of heart disorder in the fetus
Neurosciences Journal Jan 2024, 29 (1) 67;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Clinical trial in pregnant women addresses detection of heart disorder in the fetus
Neurosciences Journal Jan 2024, 29 (1) 67;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • eLetters
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Do allergic conditions increase the risk of developing Long-COVID after SARS-CoV-2 infection?
  • Robust analysis challenges theory that depression and anxiety increase cancer risk
Show more Cochrane library newsalert

Similar Articles

Navigate

  • home

More Information

  • Help

Additional journals

  • All Topics

Other Services

  • About

© 2025 Neurosciences Journal Neurosciences is copyright under the Berne Convention and the International Copyright Convention. All rights reserved. Neurosciences is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3183. Print ISSN 1319-6138.

Powered by HighWire